Week 3 Prac

Assignment 1: Prescribing for Children and Adolescents
The Assignment (1–2 pages)

Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating depression in children in children and adolescents.
Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?
Explain whether clinical practice guidelines exist for this disorder and, if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.
Support your reasoning with at least three scholarly resources, one each on the FDA-approved drug, the off-label, and a non-medication intervention for the disorder. Attach the PDFs of your sources.